Treatment delay and excessive substance use in bipolar disorder

Journal of Nervous and Mental Disease

Volumn 198, Issue 9, 2010, Pages 628-633

  Lagerberg, Trine Vik ^a   Larsson, Sara ^b   Sundet, Kjetil ^b   Hansen, Charlotte B ^b   Hellvin, Tone ^a   Andreassen, Ole A ^a   Melle, Ingrid ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Bipolar disorder; excessive substance use; treatment delay

Indexed keywords

MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; DISEASE ASSOCIATION; EDUCATION; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREDICTOR VARIABLE; PSYCHIATRIC TREATMENT; PSYCHOSIS; SEX DIFFERENCE; SUBSTANCE ABUSE; THERAPY DELAY; ADDICTION; AGE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HOSPITALIZATION; MIDDLE AGED; NONPARAMETRIC TEST; ONSET AGE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; RISK FACTOR; TIME;

ADULT; AGE FACTORS; AGE OF ONSET; BIPOLAR DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 77957089147     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3181ef3ef4     Document Type: Article

References (53)

1. Albanese MJ, Clodfelter RC Jr, Pardo TB, Ghaemi SN (2006) Underdiagnosis of bipolar disorder in men with substance use disorder. J Psychiatr Pract. 12:124-127.
2. Albanese MJ, Pies R (2004) The bipolar patient with comorbid substance use disorder: Recognition and management. CNS Drugs. 18:585-596.
3. Altamura AC, Dell'osso B, Berlin HA, Buoli M, Bassetti R, Mundo E (2009) Duration of untreated illness and suicide in bipolar disorder: A naturalistic study. Eur Arch Psychiatry Clin Neurosci. In press.
4. Baethge C, Smolka MN, Gruschka P, Berghofer A, Schlattmann P, Bauer M, Altshuler L, Grof P, Muller-Oerlinghausen B (2003a) Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr Scand. 107:260-267.
5. Baethge C, Tondo L, Bratti IM, Bschor T, Bauer M, Viguera AC, Baldessarini RJ (2003b) Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry. 48:449-457.
6. Baldessarini RJ, Perry R, Pike J (2008) Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 23:95-105.
7. Baldessarini RJ, Tondo L, Baethge CJ, Lepri B, Bratti IM (2007) Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disord. 9:386-393.
8. Baldessarini RJ, Tondo L, Hennen J (2003) Treatment-latency and previous episodes: Relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 5:169-179.
9. Baldessarini RJ, Tondo L, Hennen J, Floris G (1999) Latency and episodes before treatment: Response to lithium maintenance in bipolar I and II disorders. Bipolar Disord. 1:91-97.
10. Berk M, Dodd S, Callaly P, Berk L, Fitzgerald P, de Castella AR, Filia S, Filia K, Tahtalian S, Biffin F, Kelin K, Smith M, Montgomery W, Kulkarni J (2007) History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect Disord. 103:181-186.
11. Bizzarri JV, Sbrana A, Rucci P, Ravani L, Massei GJ, Gonnelli C, Spagnolli S, Doria MR, Raimondi F, Endicott J, Dell'Osso L, Cassano GB (2007) The spectrum of substance abuse in bipolar disorder: Reasons for use, sensation seeking and substance sensitivity. Bipolar Disord. 9:213-220.
12. Bolton JM, Robinson J, Sareen J (2009) Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord. 115:367-375.
13. Cardoso BM, Kauer SM, Dias VV, Andreazza AC, Cereser KM, Kapczinski F (2008) The impact of co-morbid alcohol-use disorder in bipolar patients. Alcohol. 42:451-457.
14. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL (2003) Suicide risk in bipolar patients: The role of co-morbid substance use disorders. Bipolar Disord. 5:58-61.
15. Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM (2003) Gender differences in prevalence, risk and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 160:883-889.
16. Goldberg JF, Ernst CL (2002) Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 63:985-991.
17. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L (1999) A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry. 60:733-740.
18. Goodwin GM (2009) Evidence-based guidelines for treating bipolar disorder: Revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 23:346-388.
19. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, Huang B (2005) Prevalence, correlates and comorbidity of bipolar I disorder and axis I and II disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 66:1205-1215. (Pubitemid 41546498)
20. Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ (2004) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry. 5:120-135.
21. Haro JM, van OJ, Vieta E, Reed C, Lorenzo M, Goetz I (2006) Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: Results from the EMBLEM study. Acta Psychiatr Scand. 113:112-120.
22. Healey C, Peters S, Kinderman P, McCracken C, Morriss R (2009) Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: A qualitative study. J Affect Disord. 113:118-126.
23. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD (2003) Screening for bipolar disorder in the community. J Clin Psychiatry. 64:53-59.
24. Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, Muller N, Lieb R (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med. 34:597-611.
25. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Maser J, Rice JA, Solomon DA, Keller MB (2003) The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: A clinical spectrum or distinct disorders? J Affect Disord. 73:19-32.
26. Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P (1998) 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 155:646-652.
27. Kessing LV (2005) Diagnostic stability in bipolar disorder in clinical practice as according to ICD-10. J Affect Disord. 85:293-299.
28. Khantzian EJ (1997) The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harv Rev Psychiatry. 4:231-244.
29. Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Smith HC (2006) Practice Guideline for the Treatment of Patients With Substance Use Disorders (2nd ed). New York (NY): American Psychiatric Association.
30. Lagerberg TV, Andreassen OA, Ringen PA, Berg AO, Larsson S, Agartz I, Sundet K, Melle I (2010) Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry. In press.
31. Larsson S, Lorentzen S, Mork E, Barrett EA, Steen NE, Lagerberg TV, Berg AO, Aminoff SR, Agartz I, Melle I, Andreassen OA (2009) Age at onset of bipolar disorder in a Norwegian catchment area sample. J Affect Disord. In press.
32. Lish JD, me-Meenan S, Whybrow PC, Price RA, Hirschfeld RM (1994) The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 31:281-294.
33. Mantere O, Suominen K, Arvilommi P, Valtonen H, Leppamaki S, Isometsa E (2008) Clinical predictors of unrecognized bipolar I and II disorders. Bipolar Disord. 10:238-244.
34. Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD (2007) Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry. 68:1172-1176.
35. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry. 62:975-983.
36. Melle I, Larsen TK, Haahr U, Friis S, Johannesen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T (2008) Prevention of negative symptom psychopathologies in first-episode schizophrenia: Two-year effects of reducing the duration of untreated psychosis. Arch Gen Psychiatry. 65:634-640.
37. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T (2004) Reducing the duration of untreated first-episode psychosis: Effects on clinical presentation. Arch Gen Psychiatry. 61:143-150. (Pubitemid 38146548)
38. Morken G, Vaaler AE, Folden GE, Andreassen OA, Malt UF (2009) Age at onset of first episode and time to treatment in in-patients with bipolar disorder. Br J Psychiatry. 194:559-560.
39. Mueser KT, Drake RE, Wallach MA (1998) Dual diagnosis: A review of etiological theories. Addict Behav. 23:717-734.
40. Oedegaard KJ, Syrstad VE, Morken G, Akiskal HS, Fasmer OB (2009) A study of age at onset and affective temperaments in a Norwegian sample of patients with mood disorders. J Affect Disord. 118:229-233.
41. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J (2003) An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord. 5:310-319.
42. Post RM, Luckenbaugh DA, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J (2008) Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry. 192:150-151.
43. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 264:2511-2518.
44. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK (1993) The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 50:85-94.
45. Sbrana A, Bizzarri JV, Rucci P, Gonnelli C, Massei JG, Ravani L, Endicott J, Maser JD, Cassano GB (2007) Family history of psychiatric disorders and alcohol and substance misuse in patients with bipolar I disorder, substance use disorder, or both. Am J Addict. 16:227-231.
46. Sonne SC, Brady KT, Morton WA (1994) Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 182:349-352.
47. Suominen K, Mantere O, Valtonen H, Arvilommi P, Leppamaki S, Isometsa E (2009) Gender differences in bipolar disorder type I and II. Acta Psychiatr Scand. 120:464-473.
48. Suominen K, Mantere O, Valtonen H, Arvilommi P, Leppamaki S, Paunio T, Isometsa E (2007) Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking. Bipolar Disord. 9:698-705.
49. ten Have M, Vollebergh W, Bijl R, Nolen WA (2002) Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): Results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord. 68:203-213. (Pubitemid 34628327)
50. Tohen M, Greenfield SF, Weiss RD, Zarate CA Jr, Vagge LM (1998) The effect of comorbid substance use disorders on the course of bipolar disorder: A review. Harv Rev Psychiatry. 6:133-141.
51. Urbanoski KA, Rush BR, Wild TC, Bassani DG, Castel S (2007) Use of mental health care services by Canadians with co-occurring substance dependence and mental disorders. Psychiatr Serv. 58:962-969.
52. Weiss RD, Kolodziej M, Griffin ML, Najavits LM, Jacobson LM, Greenfield SF (2004) Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence. J Affect Disord. 79:279-283.
53. Wu LT, Kouzis AC, Leaf PJ (1999) Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am J Psychiatry. 156:1230-1236.